FIELD: pharmaceuticals.
SUBSTANCE: invention discloses the use of a composition containing glycocholic acid (GCA), which is a bile acid, or a salt thereof, and at least one fatty acid selected from the group consisting of butyric acid or a salt thereof and oleic acid or its salts, as a medicinal product in the treatment and/or prevention of calcium malabsorption.
EFFECT: synergistic increase in calcium absorption compared to the effect of two individual components separately — bile acid and fatty acid.
13 cl, 6 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTABLE COMPOSITION FOR REDUCING LOCALIZED FAT WITHOUT PAIN SYNDROME, EDEMA AND SIDE EFFECTS AND A METHOD FOR PREPARING IT | 2018 |
|
RU2736974C1 |
| ZOOTECHNIC METHOD FOR INTRODUCTION OF VITAMIN E DERIVATIVE AND COMPOSITION | 2004 |
|
RU2375912C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| SYGETHIN-BASED PHARMACEUTICAL STRUCTURE FOR OSTEOPOROSIS PREVENTION AND TREATMENT (VERSIONS) | 2007 |
|
RU2356546C1 |
| HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT AND PREVENTION OF CANCER | 2019 |
|
RU2794340C1 |
| DRUG PREPARATION USED FOR CARTILAGE DISEASES | 2006 |
|
RU2454999C2 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE | 2019 |
|
RU2799556C2 |
| FOOD BUTYRATE AND USE THEREOF | 2020 |
|
RU2831429C2 |
| DELTA-8 DESATURASE GENES, ENZYMES ENCODED THEREBY AND USE THEREOF | 2009 |
|
RU2517615C2 |
| FOOD BUTYRATE AND ITS USE | 2020 |
|
RU2830822C2 |
